Status
145%
finanziert
Teilen
Finanzierungsdaten
Finanziert
EUR
651.191,00
Finanzierungsschwelle
EUR
450.024,00
Einzelheiten
Land
Finnland
Typologie
Eigenkapital
Sektor
GesundheitBiotechnology
Beschreibung
“Joint pain? Often the underlying cause is cartilage damage - an unsolved medical issue affecting numerous people and animals. With the COPLA Scaffold™, healing joint surface damage to regain healthy movement is now possible.”